Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Mar 28:2:57-61.
doi: 10.2174/1874364100802010057.

SKGEL® implant versus T-Flux® implant in the contralateral eye in deep sclerectomy with phacoemulsification: long-term follow-up

Frank Schreyger  1 , Gabor Scharioth, Holger Baatz
Affiliations

SKGEL® implant versus T-Flux® implant in the contralateral eye in deep sclerectomy with phacoemulsification: long-term follow-up

Frank Schreyger et al. Open Ophthalmol J. .

Abstract

Purpose: To intraindividually compare the efficacy and safety of the SKGEL(®) implant versus the T-Flux(®) implant in deep sclerectomy.

Methods: In a retrospective analysis 17 patients were identified who underwent combined phacoemulsification-deep sclerectomy and implantation of SKGEL(®) in one eye and T-Flux(®) in the contralateral eye.

Results: In eyes with SKGEL(®) the IOP decreased from 20.6+7.3 mm Hg to 14.8+5.3 mm Hg (-5.8 mm Hg or -28.1%), and in eyes with T-Flux(®) from 19.9+7.2 mm Hg to 14.7+3.3 mm Hg (-5.2 mm Hg or -26.1%, no statistically significant difference, p >0.05). Antiglaucoma medications with either implant decreased from initially 2.0+0.8 to 0.3+0.7. A qualified success was found in 17/17 eyes with T-Flux(®) and in 16/17 eyes with SKGEL(®). Complete success was achieved in 14/17 eyes with T-Flux(®) and in 13/17 eyes with SKGEL(®).

Conclusions: The IOP-lowering effect and safety of SKGEL(®) and T-Flux(®) seem to be comparable.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
Intraocular pressure (IOP) course over time D = day, M = months, (number of eyes with T-Flux® / SKGel®).
See this image and copyright information in PMC

References

    1. Ambresin A, Shaarawy T, Mermoud A. Deep sclerectomy with collagen implant in one eye compared with trabeculectomy in the other eye of the same patient. J Glaucoma. 2002;11:214–20. - PubMed
    1. Detry-Morel M, Detry MB. Five-year experience with non penetrating deep sclerectomy. Bull Soc Belge Ophtalmol. 2006;299:83–94. - PubMed
    1. Hamard P, Lachkar Y. [Non penetrating filtering surgery, evolution and results] J Fr Ophtalmol. 2002;25:527–36. - PubMed
    1. Drusedau MU, von Wolff K, Bull H, von Barsewisch B. Viscocanalostomy for primary open-angle glaucoma: the Gross Pankow experience. J Cataract Refract Surg. 2000;26:1367–73. - PubMed
    1. Stegmann R, Pienaar A, Miller D. Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg. 1999;25:316–22. - PubMed

LinkOut - more resources